Malignant neoplasm of right round ligament
ICD-10 C57.21 is a billable code used to indicate a diagnosis of malignant neoplasm of right round ligament.
C57.21 refers to a malignant neoplasm located in the right round ligament, which is a fibrous cord that extends from the uterus to the labia majora. This neoplasm is classified under gynecologic malignancies and may present with symptoms such as abdominal pain, pelvic mass, or abnormal bleeding. Diagnosis typically involves imaging studies such as ultrasound or MRI, and histopathological examination following biopsy. The staging of this malignancy is crucial for determining the appropriate treatment approach, which may include surgical resection, chemotherapy, or radiation therapy. CA-125, a tumor marker often elevated in ovarian cancer, may also be monitored, although its relevance in round ligament neoplasms is less established. The management of this condition requires a multidisciplinary approach, involving gynecologic oncologists, radiologists, and pathologists to ensure accurate diagnosis and effective treatment planning.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis of malignant neoplasms, staging evaluations, and treatment planning.
Ensure clear documentation of tumor type, size, and staging to support coding.
Imaging reports that detail findings related to the neoplasm.
Imaging for suspected malignancies and follow-up imaging post-treatment.
Radiology reports should clearly indicate the location and characteristics of the neoplasm.
Used when performing a hysterectomy due to malignancy in the round ligament.
Operative reports must detail the procedure and findings.
Gynecologic oncologists should ensure accurate coding of the procedure.
CA-125 is a tumor marker often associated with ovarian cancer. While it may be elevated in cases of malignancy in the round ligament, its utility specifically for C57.21 is less established. It is important to interpret CA-125 levels in conjunction with imaging and histopathological findings.
